Qkine 🇬🇧
High-purity, animal-free growth factors, cytokines, and complex proteins for stem cell and organoid culture in life sciences.
About Qkine
Qkine specializes in the production of high-purity, animal-free growth factors, cytokines, and complex proteins designed for life science applications, particularly in stem cell and organoid culture. Utilizing proprietary production processes and protein engineering technologies, the company addresses biological and scalability challenges while ensuring rigorous quality testing for reproducibility.
Qkine is a UK-based company founded in 2016, now around 34 people. It has raised $12.3M in disclosed funding, starting with a Seed in 2018.
Founder: Marko Hyvönen (Founder & CSO; European Molecular Biology Laboratory).
Company facts from Harmonic and public filings; team backgrounds from public profiles. Refreshed weekly.
Series B · Sep 2026
Oxford Innovation EIS Growth Fund- Oxford Innovation EIS Growth Fund — Investing across the UK in Science, Innovation and Technology. · cheques £150k – £400k
Funding history
● rounds tracked in this directory · ○ earlier rounds web-verified from public announcements. Amounts as announced; undisclosed rounds omitted.